These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29513155)

  • 1. Evaluation of orally administered telmisartan for the reduction of indirect systolic arterial blood pressure in awake, clinically normal cats.
    Coleman AE; Brown SA; Stark M; Bryson L; Zimmerman A; Zimmering T; Traas AM
    J Feline Med Surg; 2019 Feb; 21(2):109-114. PubMed ID: 29513155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of orally administered telmisartan for the treatment of systemic hypertension in cats: Results of a double-blind, placebo-controlled, randomized clinical trial.
    Coleman AE; Brown SA; Traas AM; Bryson L; Zimmering T; Zimmerman A
    J Vet Intern Med; 2019 Mar; 33(2):478-488. PubMed ID: 30851066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of the pressor response to exogenous angiotensin by angiotensin receptor blockers and benazepril hydrochloride in clinically normal cats.
    Jenkins TL; Coleman AE; Schmiedt CW; Brown SA
    Am J Vet Res; 2015 Sep; 76(9):807-13. PubMed ID: 26309109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of orally administered enalapril on blood pressure and hemodynamic response to vasopressors during isoflurane anesthesia in healthy dogs.
    Coleman AE; Shepard MK; Schmiedt CW; Hofmeister EH; Brown SA
    Vet Anaesth Analg; 2016 Sep; 43(5):482-94. PubMed ID: 26848816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gabapentin on ambulatory, direct, systemic arterial blood pressure in apparently healthy cats in the at-home and in-clinic environments.
    De Lombaert MC; Lourenço BN; Coleman AE; Arne AM; Berghaus RD; Schmiedt CW
    J Feline Med Surg; 2023 Aug; 25(8):1098612X231188770. PubMed ID: 37594245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of long-term oral telmisartan treatment in cats with hypertension: Results of a prospective European clinical trial.
    Glaus TM; Elliott J; Herberich E; Zimmering T; Albrecht B
    J Vet Intern Med; 2019 Mar; 33(2):413-422. PubMed ID: 30561059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
    McGill JB; Reilly PA
    Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of ambulatory blood pressure monitoring to evaluate the selective angiotensin II receptor antagonist, telmisartan, and other antihypertensive drugs.
    Neutel JM
    Blood Press Monit; 2000; 5 Suppl 1():S35-40. PubMed ID: 10904241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo.
    Manolis AJ; Reid JL; de Zeeuw D; Murphy MB; Seewaldt-Becker E; Köster J;
    J Hypertens; 2004 May; 22(5):1033-7. PubMed ID: 15097245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amlodipine: a randomized, blinded clinical trial in 9 cats with systemic hypertension.
    Snyder PS
    J Vet Intern Med; 1998; 12(3):157-62. PubMed ID: 9595376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
    Šutalo S; Ruetten M; Hartnack S; Reusch CE; Kook PH
    J Vet Intern Med; 2015; 29(3):840-6. PubMed ID: 25966746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B; Gerwe M; Braun M; Funken C
    Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH; Matzek KM; Kempthorne-Rawson J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azilsartan medoxomil: a review of its use in hypertension.
    Perry CM
    Clin Drug Investig; 2012 Sep; 32(9):621-39. PubMed ID: 22877322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Littlejohn T; Mroczek W; Marbury T; VanderMaelen CP; Dubiel RF
    Can J Cardiol; 2000 Sep; 16(9):1123-32. PubMed ID: 11021956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained antihypertensive activity of telmisartan compared with valsartan.
    Lacourcière Y; Krzesinski JM; White WB; Davidai G; Schumacher H
    Blood Press Monit; 2004 Aug; 9(4):203-10. PubMed ID: 15311147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic interaction between rosuvastatin and telmisartan in healthy Korean male volunteers: a randomized, open-label, two-period, crossover, multiple-dose study.
    Son M; Kim Y; Lee D; Roh H; Son H; Guk J; Jang SB; Nam SY; Park K
    Clin Ther; 2014 Aug; 36(8):1147-58. PubMed ID: 24998012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and safety of telmisartan 80 mg once daily compared with enalapril 20 mg once daily in patients with mild-to-moderate hypertension: results of a multicentre study.
    Alcocer L; Fernandez-Bonetti P; Campos E; Dominguez-Henkel R; de la Fuente JJ; Segovia-Ayala C
    Int J Clin Pract Suppl; 2004 Dec; (145):23-8. PubMed ID: 15617455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan Exacerbates Cisplatin-Induced Nephrotoxicity in a Mouse Model.
    Hosoda A; Matsumoto Y; Toriyama Y; Tsuji T; Yoshida Y; Masamichi S; Kohno T
    Biol Pharm Bull; 2020; 43(9):1331-1337. PubMed ID: 32879207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.